Psilocybin safety: real risks, dangerous drug combinations and where to get help
Psilocybin's physical toxicity is low, but it isn't risk-free. The real dangers are psychological crises, risky behavior during a trip, a small set of dangerous drug combinations, and products that aren't what they claim. Here's what the research shows, with the help lines to keep handy.
On this page
Need help right now?
- Medical emergency (seizure, chest pain, trouble breathing, unresponsive): call 911
- Poison Control, free and 24/7: 1-800-222-1222
- Fireside Project psychedelic peer support, call or text 62-FIRESIDE (623-473-7433), 11 a.m. to 11 p.m. Pacific, every day
- Thoughts of suicide or a mental health crisis: call or text 988, 24/7
How physically dangerous is psilocybin?
Compared with most drugs, psilocybin has low physical toxicity. Researchers estimate a lethal dose would be on the order of a thousand times an effective dose, and deaths caused by psilocybin alone are extremely rare; most fatal cases involving hallucinogens also involve other substances or dangerous behavior. In a 2017 global survey of more than 9,000 people who had used magic mushrooms in the past year, 0.2% reported needing emergency medical treatment, and nearly all were back to normal within 24 hours.
Common short-term side effects in clinical trials include headache, nausea, anxiety, dizziness and a temporary rise in blood pressure and heart rate. In a 2024 analysis of six randomized trials, these generally resolved within 48 hours.
The psychological risks are the main concern
- Challenging experiences. In a survey of nearly 2,000 people describing their worst "bad trip," 11% said they put themselves or others at risk of physical harm and 2.7% sought medical help. Most also said they benefited from the experience, but the risk of panic, confusion and dangerous behavior is real, especially without a sober, trusted person present.
- Psychosis and mania. Lasting psychosis after psilocybin is rare and usually involves people with a personal or family history of psychotic or bipolar disorders. A large 2025 Ontario study found that people who went to an emergency department for hallucinogen use had a much higher risk of a later schizophrenia-spectrum diagnosis than the general population (about 4% vs 0.15% within three years).
- Lingering visual effects. Hallucinogen persisting perception disorder (HPPD), lasting visual disturbances, is uncommon; in one U.S. survey, 1.3% of people who had used any psychedelic said they had been told they had it.
- In clinical trials, a 2024 review of 214 studies found serious adverse events were essentially absent in healthy volunteers but occurred in about 4% of participants with existing psychiatric conditions, including worsening depression and suicidal behavior.
Who should avoid psilocybin
Research safety guidelines and clinical trials exclude people with:
- A personal or close family history of psychosis, schizophrenia or bipolar disorder
- Uncontrolled high blood pressure or significant heart disease
- Pregnancy
- Current use of lithium (see below)
Oregon service centers and Colorado healing centers screen for these issues and can turn people away.
Dangerous and risky drug combinations
| Combined with | Risk | What's known |
|---|---|---|
| Lithium | Dangerous | In an analysis of 62 reports of lithium combined with psychedelics, 47% described seizures and 39% sought medical attention |
| Tramadol | Unsafe | Tramadol lowers the seizure threshold; its label warns of seizures and serotonin syndrome risk with other serotonergic drugs |
| MAOIs | Caution | MAO enzymes help break down psilocin, so MAOIs can change effects unpredictably; reports describe both stronger and blunted effects |
| SSRIs and SNRIs | Often reduced effect | Many people report weaker effects; serotonin syndrome is uncommon without an MAOI. Don't stop an antidepressant on your own |
| Antipsychotics | Reduced effect | Drugs such as risperidone and haloperidol can blunt or alter effects |
| Cannabis | Caution | Can make the experience more intense and unpredictable, and raise the chance of a challenging trip |
| Alcohol and stimulants | Caution | Impair judgment and add cardiovascular strain; deaths involving hallucinogens often involve other substances |
Practical harm reduction
- Know what you have. Many "mushroom" products contain no psilocybin, and real mushrooms vary widely in strength. See fake mushroom products.
- Don't forage. Some deadly mushrooms, including some Galerina species that contain the same liver-destroying toxins as the death cap, can be mistaken for psilocybin mushrooms.
- Have a sober, trusted person present, in a safe, familiar place.
- Don't drive or do anything risky until the effects are fully gone. See how long shrooms last.
- Don't mix with lithium or tramadol, and be cautious with alcohol and cannabis.
- Prefer supervised settings where they're legal: Oregon and Colorado.
Harm-reduction organizations
- Fireside Project: free, confidential psychedelic peer support by phone or text. Not a suicide hotline; for crisis, call or text 988.
- DanceSafe: drug-checking kits and fentanyl test strips.
- TripSit: live chat support and a drug combinations chart.
- Zendo Project: psychedelic peer support at events, and training.
- SAMHSA National Helpline: 1-800-662-4357, free, 24/7 treatment referrals.
Frequently asked questions
Can you overdose on magic mushrooms?
A fatal overdose from psilocybin alone is extremely unlikely; researchers estimate a lethal amount would be roughly a thousand times an effective dose. But taking too much can cause severe anxiety, confusion and dangerous behavior, and products may contain other drugs. If someone is unresponsive, seizing or struggling to breathe, call 911.
Is it safe to take psilocybin on antidepressants?
SSRIs and SNRIs often weaken psilocybin's effects, and serious serotonin syndrome is uncommon unless an MAOI is involved. Lithium is the dangerous exception, with frequent seizure reports. Never stop or change a psychiatric medication without your prescriber, since withdrawal carries its own risks.
What should I do if someone is having a bad trip?
Move them somewhere calm and safe, stay with them, speak reassuringly and remind them the effects will pass. Call or text Fireside Project at 62-FIRESIDE for peer support. Call 911 for seizures, chest pain, trouble breathing, unresponsiveness, or if they're a danger to themselves or others.
Who should not take psilocybin?
People with a personal or family history of psychosis, schizophrenia or bipolar disorder, people who are pregnant, those with uncontrolled high blood pressure or significant heart disease, and anyone taking lithium. These are the groups clinical trials exclude.
Sources
- Johnson et al., the abuse potential of medical psilocybin, Neuropharmacology, 2018.
- Gable, acute toxicity of drugs versus regulatory status, Addiction, 2004.
- Kopra et al., emergency treatment after magic mushroom use (Global Drug Survey), Journal of Psychopharmacology, 2022.
- Yerubandi et al., adverse events in psilocybin trials, JAMA Network Open, 2024.
- Carbonaro et al., survey of challenging experiences after psilocybin, Journal of Psychopharmacology, 2016.
- Myran et al., hallucinogen emergency visits and schizophrenia-spectrum disorders, JAMA Psychiatry, 2025.
- Simonsson et al., psychedelic use and HPPD in a U.S. sample, Psychopharmacology, 2025.
- Hinkle et al., adverse events in studies of classic psychedelics, JAMA Psychiatry, 2024.
- Johnson, Richards and Griffiths, human hallucinogen research: guidelines for safety, Journal of Psychopharmacology, 2008.
- Nayak et al., lithium and psychedelics: seizure reports, Pharmacopsychiatry, 2021.
- Halman et al., drug-drug interactions involving classic psychedelics, Journal of Psychopharmacology, 2024.
- Gukasyan et al., antidepressants and psilocybin effects, Journal of Psychopharmacology, 2023.
- Malcolm and Thomas, serotonin toxicity of serotonergic psychedelics, Psychopharmacology, 2022.
- Kuc et al., cannabis use alongside psychedelics, Psychopharmacology, 2022.
- TripSit drug combinations data, accessed October 20, 2026.
- Fireside Project, accessed October 20, 2026.
- America's Poison Centers, accessed October 20, 2026.